Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Katharina Brandl

    TitleAssistant Adjunct Professor
    SchoolUniversity of California, San Diego
    DepartmentSchool of Pharmacy and Pharmaceutical Science
    Address9500 Gilman Drive #0657
    CA La Jolla 92093
    Phone858-822-6853
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Brandl K. Response to: Further evidence for curricular influence on student connectedness. Med Teach. 2017 Oct; 39(10):1104. PMID: 28817354.
        View in: PubMed
      2. Brandl K, Schnabl B. Intestinal microbiota and nonalcoholic steatohepatitis. Curr Opin Gastroenterol. 2017 May; 33(3):128-133. PMID: 28257306.
        View in: PubMed
      3. Brandl K, Schneid SD, Smith S, Winegarden B, Mandel J, Kelly CJ. Small group activities within academic communities improve the connectedness of students and faculty. Med Teach. 2017 Aug; 39(8):813-819. PMID: 28440094.
        View in: PubMed
      4. Brandl K, Adler D, Kelly C, Taylor P, Best BM. Effect of a Dedicated Pharmacy Student Summer Research Program on Publication Rate. Am J Pharm Educ. 2017 Apr; 81(3):48. PMID: 28496268.
        View in: PubMed
      5. Brandl K, Kumar V, Eckmann L. Gut-liver axis at the frontier of host-microbial interactions. Am J Physiol Gastrointest Liver Physiol. 2017 May 01; 312(5):G413-G419. PMID: 28232456.
        View in: PubMed
      6. Brandl K, Mandel J, Winegarden B. Student evaluation team focus groups increase students' satisfaction with the overall course evaluation process. Med Educ. 2017 Feb; 51(2):215-227. PMID: 27917517.
        View in: PubMed
      7. Armour C, Schneid SD, Brandl K. Writing on the board as students' preferred teaching modality in a physiology course. Adv Physiol Educ. 2016 Jun; 40(2):229-33. PMID: 27105742.
        View in: PubMed
      8. Hartmann P, Seebauer CT, Mazagova M, Horvath A, Wang L, Llorente C, Varki NM, Brandl K, Ho SB, Schnabl B. Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity. Am J Physiol Gastrointest Liver Physiol. 2016 Mar 01; 310(5):G310-22. PMID: 26702135; PMCID: PMC4773827 [Available on 03/01/17].
      9. Brandl K, Schnabl B. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease? Expert Rev Gastroenterol Hepatol. 2015; 9(8):1069-76. PMID: 26088524; PMCID: PMC4828034.
      10. Arnold P, Lu X, Amirahmadi F, Brandl K, Arnold JM, Feng Q. Recombinant human annexin A5 inhibits proinflammatory response and improves cardiac function and survival in mice with endotoxemia. Crit Care Med. 2014 Jan; 42(1):e32-41. PMID: 24145837.
        View in: PubMed
      11. Hartmann P, Chen P, Wang HJ, Wang L, McCole DF, Brandl K, Stärkel P, Belzer C, Hellerbrand C, Tsukamoto H, Ho SB, Schnabl B. Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice. Hepatology. 2013 Jul; 58(1):108-19. PMID: 23408358; PMCID: PMC3695050.
      12. Brandl K, Beutler B. Creating diseases to understand what prevents them: genetic analysis of inflammation in the gastrointestinal tract. Curr Opin Immunol. 2012 Dec; 24(6):678-85. PMID: 23123276; PMCID: PMC3729218.
      13. Arnold CN, Barnes MJ, Berger M, Blasius AL, Brandl K, Croker B, Crozat K, Du X, Eidenschenk C, Georgel P, Hoebe K, Huang H, Jiang Z, Krebs P, La Vine D, Li X, Lyon S, Moresco EM, Murray AR, Popkin DL, Rutschmann S, Siggs OM, Smart NG, Sun L, Tabeta K, Webster V, Tomisato W, Won S, Xia Y, Xiao N, Beutler B. ENU-induced phenovariance in mice: inferences from 587 mutations. BMC Res Notes. 2012 Oct 24; 5:577. PMID: 23095377; PMCID: PMC3532239.
      14. Brandl K, Tomisato W, Li X, Neppl C, Pirie E, Falk W, Xia Y, Moresco EM, Baccala R, Theofilopoulos AN, Schnabl B, Beutler B. Yip1 domain family, member 6 (Yipf6) mutation induces spontaneous intestinal inflammation in mice. Proc Natl Acad Sci U S A. 2012 Jul 31; 109(31):12650-5. PMID: 22802641; PMCID: PMC3412000.
      15. Rutschmann S, Crozat K, Li X, Du X, Hanselman JC, Shigeoka AA, Brandl K, Popkin DL, McKay DB, Xia Y, Moresco EM, Beutler B. Hypopigmentation and maternal-zygotic embryonic lethality caused by a hypomorphic mbtps1 mutation in mice. G3 (Bethesda). 2012 Apr; 2(4):499-504. PMID: 22540041; PMCID: PMC3337478.
      16. Brandl K, Tomisato W, Beutler B. Inflammatory bowel disease and ADAM17 deletion. N Engl J Med. 2012 Jan 12; 366(2):190; author reply 190. PMID: 22236242.
        View in: PubMed
      17. Won S, Eidenschenk C, Arnold CN, Siggs OM, Sun L, Brandl K, Mullen TM, Nemerow GR, Moresco EM, Beutler B. Increased susceptibility to DNA virus infection in mice with a GCN2 mutation. J Virol. 2012 Feb; 86(3):1802-8. PMID: 22114338; PMCID: PMC3264364.
      18. Brandl K, Sun L, Neppl C, Siggs OM, Le Gall SM, Tomisato W, Li X, Du X, Maennel DN, Blobel CP, Beutler B. MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands. Proc Natl Acad Sci U S A. 2010 Nov 16; 107(46):19967-72. PMID: 21041656; PMCID: PMC2993336.
      19. Xiao N, Eidenschenk C, Krebs P, Brandl K, Blasius AL, Xia Y, Khovananth K, Smart NG, Beutler B. The Tpl2 mutation Sluggish impairs type I IFN production and increases susceptibility to group B streptococcal disease. J Immunol. 2009 Dec 15; 183(12):7975-83. PMID: 19923465.
        View in: PubMed
      20. Jia T, Leiner I, Dorothee G, Brandl K, Pamer EG. MyD88 and Type I interferon receptor-mediated chemokine induction and monocyte recruitment during Listeria monocytogenes infection. J Immunol. 2009 Jul 15; 183(2):1271-8. PMID: 19553532; PMCID: PMC2735446.
      21. Gross P, Brandl K, Dierkes C, Schölmerich J, Salzberger B, Glück T, Falk W. Lipopolysaccharide-trap-Fc, a multifunctional agent to battle gram-negative bacteria. Infect Immun. 2009 Jul; 77(7):2925-31. PMID: 19433546; PMCID: PMC2708546.
      22. Blasius AL, Brandl K, Crozat K, Xia Y, Khovananth K, Krebs P, Smart NG, Zampolli A, Ruggeri ZM, Beutler BA. Mice with mutations of Dock7 have generalized hypopigmentation and white-spotting but show normal neurological function. Proc Natl Acad Sci U S A. 2009 Feb 24; 106(8):2706-11. PMID: 19202056; PMCID: PMC2650330.
      23. Brandl K, Rutschmann S, Li X, Du X, Xiao N, Schnabl B, Brenner DA, Beutler B. Enhanced sensitivity to DSS colitis caused by a hypomorphic Mbtps1 mutation disrupting the ATF6-driven unfolded protein response. Proc Natl Acad Sci U S A. 2009 Mar 03; 106(9):3300-5. PMID: 19202076; PMCID: PMC2651297.
      24. Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, Schnabl B, DeMatteo RP, Pamer EG. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature. 2008 Oct 09; 455(7214):804-7. PMID: 18724361; PMCID: PMC2663337.
      25. Schnabl B, Brandl K, Fink M, Gross P, Taura K, Gäbele E, Hellerbrand C, Falk W. A TLR4/MD2 fusion protein inhibits LPS-induced pro-inflammatory signaling in hepatic stellate cells. Biochem Biophys Res Commun. 2008 Oct 17; 375(2):210-4. PMID: 18694726.
        View in: PubMed
      26. Brandl K, Plitas G, Schnabl B, DeMatteo RP, Pamer EG. MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. J Exp Med. 2007 Aug 06; 204(8):1891-900. PMID: 17635956; PMCID: PMC2118673.
      27. Brandl K, Glück T, Hartmann P, Salzberger B, Falk W. A designed TLR4/MD-2 complex to capture LPS. J Endotoxin Res. 2005; 11(4):197-206. PMID: 16176655.
        View in: PubMed